- Sam was only three years old when he started to experience fatigue and bruising and was diagnosed with aplastic anaemia. He was treated with immunosuppressants, but 17 years later…
- Anthony Nolan is proud to facilitate three stem cell transplants a day. Though they give patients a vital second chance of life, they can also lead to severe post-transplant…
- Against daily news articles on COVID-19’s impact and possible new treatments or vaccines, it can be very hard to get a clear…
- In this blog, our Science Communications Manager, Jonathan Kay, looks at a recent study that highlights the potential benefits of selecting a cord blood transplant over a matched…
- Umbilical cord blood (UCB) has huge potential, not only as a successful alternative source of hematopoietic blood cells for transplant/clinical application, but in research and…
- Ensuring care has the patient at the centre is a key aim for the NHS and something we’re particularly interested in at Anthony Nolan. Our post-transplant care pathway sets out one…
- Here, Anthony Nolan’s Chief Executive, Henny Braund, gives an overview of current and emerging treatments for blood cancer and the developments needed to give patients the best…
- Through the Anthony Nolan Cell & Gene Therapy Service’s provision of cellular material to cell and gene therapy researchers, we are familiar with industry standards and…
- The NHS Long-Term Plan commits to exploring new payment models to ensure that patients are able to receive the right care, in the right place, at the right time. The COVID-19…
- Volunteering Fill in this form and we will let you know how to join the Marrow group on your campus or get in touch about setting up a group. If you are already a…
This page has been auto translated by Google Translate. Confirm any health information with your own medical team before acting upon it. All printed materials and PDFs are available in English only.